This document is a Convertible Promissory Note issued by OH2 Laboratories, LLC, a Delaware limited liability company, as part of a series of similar notes under a Convertible Promissory Note Purchase Agreement dated March 9, 2015. The note outlines the repayment terms, interest rate, conversion conditions, maturity, and default events. It includes provisions for conversion into equity securities upon a qualified financing or sale of the company, and details the rights and obligations of the holder and the company.
documents/EFTA01113689.pdf
{}